Year All2024202320222021202020192018201720162015 Poseida Therapeutics Appoints Two Independent Directors, Adding Leaders for Compensation and Governance Functions January 4, 2019 Poseida Therapeutics Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Product Candidate at the 2018 American Society of Hematology Annual Meeting December 3, 2018 Poseida Therapeutics to Provide Update on Phase 1 Study of P-BCMA-101 at the 2018 American Society of Hematology Annual Meeting November 29, 2018 Poseida Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for P-BCMA-101 November 5, 2018 Poseida Therapeutics Appoints Marcy Graham as Vice President, Corporate Affairs October 9, 2018 Poseida Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory Product in Patients with Relapsed/Refractory Multiple Myeloma September 5, 2018 Poseida Therapeutics’ Clinical Update of BCMA-specific CAR-T Program Selected as a Late Breaking Presentation at the 4th Annual CAR-TCR Summit 2018 August 29, 2018 Teneobio and Poseida Expand Their Partnership to Develop UniDabs™ for Advanced CAR-T Therapies August 7, 2018 Poseida Awarded $3.99 Million CIRM Grant to Support Preclinical Development of P-PSMA-101, a T Stem Cell Memory CAR-T Therapy for Prostate Cancer July 20, 2018 Poseida Therapeutics Appoints John P. Schmid to Board of Directors July 19, 2018
Poseida Therapeutics Appoints Two Independent Directors, Adding Leaders for Compensation and Governance Functions January 4, 2019
Poseida Therapeutics Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Product Candidate at the 2018 American Society of Hematology Annual Meeting December 3, 2018
Poseida Therapeutics to Provide Update on Phase 1 Study of P-BCMA-101 at the 2018 American Society of Hematology Annual Meeting November 29, 2018
Poseida Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for P-BCMA-101 November 5, 2018
Poseida Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory Product in Patients with Relapsed/Refractory Multiple Myeloma September 5, 2018
Poseida Therapeutics’ Clinical Update of BCMA-specific CAR-T Program Selected as a Late Breaking Presentation at the 4th Annual CAR-TCR Summit 2018 August 29, 2018
Teneobio and Poseida Expand Their Partnership to Develop UniDabs™ for Advanced CAR-T Therapies August 7, 2018
Poseida Awarded $3.99 Million CIRM Grant to Support Preclinical Development of P-PSMA-101, a T Stem Cell Memory CAR-T Therapy for Prostate Cancer July 20, 2018